Cargando…

Massive Left Atrial Thrombi during Dabigatran Therapy for Nonvalvular Atrial Fibrillation

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Bachvarova, Velislava, Bucci, Claudia, Ho, Natalie, Yazdan-Ashoori, Payam, Morgan, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	A Multiplex of Mass
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058275/ https://www.ncbi.nlm.nih.gov/pubmed/30062280 http://dx.doi.org/10.1016/j.case.2017.06.003

Ejemplares similares

A Large Cardiac Papillary Fibroelastoma Arising from the Coumadin Ridge: Unusual Location and Presentation
por: Xu, Bo, et al.
Publicado: (2017)

Asymptomatic Recurrence of Right Ventricular Myxoma after Excision of Four-Chamber Myxoma
por: Chen, Cheng, et al.
Publicado: (2017)

Left Atrial Thrombi Masquerading as Myxomas: Mini Case Series and Literature Review
por: Mahmoud, Osama, et al.
Publicado: (2020)

Construction of a Clinical Predictive Model of Left Atrial and Left Atrial Appendage Thrombi in Patients with Nonvalvular Atrial Fibrillation
por: Yin, Lei, et al.
Publicado: (2022)

Dabigatran Therapy Resulting in the Resolution of Rivaroxaban-resistant Left Atrial Appendage Thrombi in Patients with Atrial Fibrillation
por: Watanabe, Tetsuya, et al.
Publicado: (2017)

Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin
por: Watanabe, Tetsuya, et al.
Publicado: (2016)

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
por: Chan, Yi‐Hsin, et al.
Publicado: (2018)

A Case of a Left Atrial Mass in an Orthotopic Heart Transplant Recipient
por: Hale, Andrew, et al.
Publicado: (2019)

Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation
por: Li, Xiaoye, et al.
Publicado: (2021)

Dabigatran for Stroke Prevention in Nonvalvular Atrial Fibrillation: Answers to Challenging “Real-World” Questions
por: Ferreira, Jorge, et al.
Publicado: (2012)

The Comparison of Therapeutic Efficacy Between Dabigatran Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation
por: Li, Hongxia, et al.
Publicado: (2021)

Cardiac Arrest after a Transatlantic Flight in a Patient with a Large Left Atrial Myxoma
por: Wedin, Johan O., et al.
Publicado: (2019)

A Rare Cause of Left Atrial Mass
por: Seghatol-Eslami, Frank, et al.
Publicado: (2020)

Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Collado, Fareed Moses S., et al.
Publicado: (2021)

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
por: Martinez, Brandon K., et al.
Publicado: (2018)

Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
por: Brown, Joshua D., et al.
Publicado: (2016)

Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
por: Zhou, Xue, et al.
Publicado: (2020)

Submassive Pulmonary Embolism and Left Atrial Thrombus
por: Konik, Ewa, et al.
Publicado: (2018)

Comparative Assessment of the Anticoagulant Activity of Rivaroxaban and Dabigatran in Patients With Nonvalvular Atrial Fibrillation: A Noninterventional Study
por: Tsantes, Argirios E., et al.
Publicado: (2016)

Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance
por: Inoue, Hiroshi, et al.
Publicado: (2016)

Ectopic Liver Tissue Presenting as a Right Atrial Mass on Echocardiography
por: Izzo, Brett A., et al.
Publicado: (2017)

Cost of dabigatran for atrial fibrillation
por: Gage, Brian F
Publicado: (2011)

Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention
por: Yu, Yunan, et al.
Publicado: (2022)

Effects of Left Atrial Appendage Closure on Neuroendocrine Function in Patients with Nonvalvular Atrial Fibrillation
por: Wang, Fei, et al.
Publicado: (2022)

Routine Coagulation Tests in Patients With Nonvalvular Atrial Fibrillation Under Dabigatran and Rivaroxaban Therapy: An Affordable and Reliable Strategy?
por: Silva, Vanessa M., et al.
Publicado: (2019)

Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review
por: Milling, Truman J., et al.
Publicado: (2017)

Association Between the Change in Total Bilirubin and Risk of Bleeding Among Patients With Nonvalvular Atrial Fibrillation Taking Dabigatran
por: Xiong, Yurong, et al.
Publicado: (2020)

A Left Atrial Thrombus Mimic: Value of Ultrasound Enhancing Agents during Transesophageal Echocardiography
por: Wehbe, Ramsey M., et al.
Publicado: (2020)

Bioprosthetic Valve Thrombosis while on a Novel Oral Anticoagulant for Atrial Fibrillation
por: O'Callaghan, Marissa, et al.
Publicado: (2018)

Dabigatran for left atrial thrombus
por: Morita, Sae, et al.
Publicado: (2013)

Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation
por: Summaria, Francesco, et al.
Publicado: (2018)

Novel Models for the Prediction of Left Atrial Appendage Thrombus in Patients with Chronic Nonvalvular Atrial Fibrillation
por: Van Chien, Do, et al.
Publicado: (2019)

Systemic Immune-Inflammation Index as a Predictor of Left Atrial Thrombosis in Nonvalvular Atrial Fibrillation
por: Dolu, Abdullah Kadir, et al.
Publicado: (2023)

Permanent left atrial thrombi after multiple atrial fibrillation ablations: Acquired Virchow’s triad?
por: Ali, Saif, et al.
Publicado: (2022)

Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation
por: Chen, Yu-Yang, et al.
Publicado: (2016)

Left atrial epicardial adipose tissue is closely associated with left atrial appendage flow velocity in patients with nonvalvular atrial fibrillation
por: Shao, Yameng, et al.
Publicado: (2022)

Prognostic Implications of Left Atrial Spontaneous Echo Contrast with Catheter Ablation of Nonvalvular Atrial Fibrillation Patients with Left Atrial Dilation
por: Lin, Changjian, et al.
Publicado: (2022)

Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups
por: Gómez-Outes, Antonio, et al.
Publicado: (2013)

Left Atrial Appendage Depth and Tachycardia Bradycardia Syndrome as Important Predictors of Left Atrial Appendage Thrombus in Patients with Nonvalvular Atrial Fibrillation
por: He, Yinge, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ak8o2ufhet8qmihsmdc649fg4a